Regulation of pro-and anti-inflammatory host responses

Contributions to Microbiology

Volumn 17, Issue , 2011, Pages 125-136

  Van Der Poll, Tom ^a   Van Zoelen, Marieke A D ^a   Wiersinga, W Joost ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MULTIPLE ORGAN FAILURE; PATHOLOGY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

HUMANS; IMMUNE TOLERANCE; MULTIPLE ORGAN FAILURE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84926125719     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000324026     Document Type: Article

References (26)

1. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-871.
2. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330: 662-664.
3. van der Poll T, Opal SM: Host-pathogen interactions in sepsis. Lancet Infect Dis 2008;8:32-43.
4. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S: Host innate immune receptors and beyond: Making sense of microbial infections. Cell Host Microbe 2008;3:352-363.
5. Bianchi ME: DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81: 1-5.
6. Liew FY, Xu D, Brint EK, O'Neill LA: Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005;5:446-458.
7. von Bernuth H, Picard C, Jin Z, et al: Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008;321:691-696.
8. Ku CL, von Bernuth H, Picard C, et al: Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007;204:2407-2422.
9. Schroder NW, Schumann RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005;5: 156-164.
10. Stutz A, Golenbock DT, Latz E: Inflammasomes: Too big to miss. J Clin Invest 2009;119:3502-3511.
11. Klesney-Tait J, Turnbull IR, Colonna M: The TREM receptor family and signal integration. Nat Immunol 2006;7:1266-1273.
12. Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM: Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med 2010;38:72-83.
13. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000;6:164-170.
14. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
15. Ramasamy R, Yan SF, Schmidt AM: RAGE: Therapeutic target and biomarker of the inflammatory response -the evidence mounts. J Leukoc Biol 2009; 86:505-512.
16. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J: Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13: 1042-1049.
17. van Zoelen MA, Vogl T, Foell D, Van Veen SQ, van Till JW, Florquin S, Tanck MW, Wittebole X, Laterre PF, Boermeester MA, Roth J, van der Poll T: Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Respir Crit Care Med 2009;180:1098-1106.
18. Guo RF, Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol 2005;23:821-852.
19. Levi M, van der Poll T: Inflammation and coagulation. Crit Care Med 2010;38:S26-S34.
20. Mosnier LO, Zlokovic BV, Griffin JH: The cytoprotective protein C pathway. Blood 2007;109: 3161-3172.
21. Weiler H, Ruf W: Activated protein C in sepsis: The promise of nonanticoagulant activated protein C. Curr Opin Hematol 2008;15:487-493.
22. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M: Protease-activated receptors: Novel PARtners in innate immunity. Trends Immunol 2007;28:541-550.
23. Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C, Covic L, Kuliopulos A: 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 2007;8:1303-1312.
24. Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, Derian CK, Andrade-Gordon P, Rosen H, Ruf W: Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008;452:654-658.
25. Tracey KJ: Reflex control of immunity. Nat Rev Immunol 2009;9:418-428.
26. Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6:813-822.